Skip to main content

Diabetes Mellitus: Pharmacotherapy- Glinides and Biguanides!

 PHARMACOTHERAPY

2.NONSULFONYLUREA SECRETAGOGUES (GLINIDES)

  • Although producing the same effects as sulfonyl ureas, Non sulfonylurea secretogogues also referred to as Glinides or Meglitinides have rapid onset and short duration of action.

Mechanism of Action:

  • Glinides produce a pharmacological action by interacting with ATP-Sensitive potassium channels on the beta cells; however, this binding is to a receptor adjacent to those with which the sulfonyl ureas bind.

Clinical Uses:

  • The primary benefit is in reducing post-meal glucose levels.
  • These agents have resulted in a reduction of 0.8-1% A1c levels.

Indications:

  • Because they have a rapid onset of action, Glinides are supposed to be taken 15-30 minutes before the meal.

Therapy:

  • They may also be used in combination therapy with other drugs to achieve synergistic effects.
  • Combinations with Biguanides is mostly used.


3.BIGUANIDES

  • Biguanides include Metformin as the Drug of choice for T 2 DM.

Mechanism of Actions:

  • Biguanides are thought to lower the blood glucose levels by decreasing hepatic glucose production and increasing insulin sensitivity in both hepatic and peripheral muscle tissues; however, the exact mechanism of action is unknown. 

Clinical uses:

  • Metformin reduces both Fasting Blood Glucose levels and post-meal glucose levels.
  • It has shown to reduce A1c levels by 1.5-2% and FPG levels by 60-80mg/dL when used as a monotherapy.
  • Unlike sulfonylureas, metformin retains the ability to reduce fasting blood glucose levels when they are used over 300mg/dL.
  • Metformin does not affect insulin release from beta cells of the pancreas, so hypoglycemia is not a common side effect.
  • Metformin significantly reduces all-cause mortality and the risk of strokes in overweight patients with T2DM compared to the insensitivity therapy with sulfonylurea or Insulin.
  • It also reduces Diabetes-related death and Myocardial infarction as compared with a conventional Arm therapy.
  • ADA treatment algorithm considers Lifestyle modification and Metformin therapy as the first line therapy for T 2 DM 
  • Metformin has shown to produce beneficial effects on serum lipid levels and has become first-line agents for T2 DM patients with metabolic syndrome.
  • On average, Triglyceride levels and LDL levels may be reduced by as much as 18.69%-12.09% respectively and HDL levels may improve by as much as 1.17%.

Therapy:

  • Metformin is often used in combination with sulfonyl urea or Thiazolidinedione (TZD) for synergistic effects.

Pharmacokinetics:

  • Metformin does not undergo significant protein binding and is eliminated from the body via urine unchanged.

Contraindications:

  • Metformin is contraindicated in patients with:

  1. patients having creatinine clearance less than 60mL/min.
  2. Patients with serum creatinine levels > than or = to 1.4mg/dL in women and 1.5mg/dL in men.
  3. It should not be initiated in patients of 80 years of age or older unless renal function has been established.
  4. Patients undergoing radiographic procedures in which nephrotoxic dye is used.
  5. Biguanides inhibit mitochondrial oxidation of lactic acid, thereby increasing the chances of lactic acidosis occurring..
  6. Metformin should be withheld in pt. with cases of hypoxemia, sepsis or dehydration.
  7. Patients should avoid consumption of excessive alcohol with Metformin intake.

Adverse Drug Reactions:

  • Primary side effects include:

                         GIT upset, Decreased appetite, Nausea, Diarrhea

  • Interference with Vitamin B12 absorption is also reported.


Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Non-Pharmacological Therapy--MNT!

 NON PHARMACOLOGICAL THERAPY  MNT Glycemic Index Dietary supplements Weight measurements Physical Activity Psychological assessment Immunizations 1. MEDICAL NUTRITION THERAPY (MNT)  " Medical Nutrition Therapy (MNT) is a term used by the ADA to describe the optimal condition of caloric intake with other aspects of diabetes therapy (Insulin, Exercise, Weight loss)". The ADA has issued recommendations for three types of MNT: Primary prevention measures of MNT are directed at preventing or delaying the onset of type 2 Diabetes in high-risk individuals (obese or with pre-diabetes) by promoting weight reduction. Secondary prevention measures of MNT are directed at preventing or delaying-related complications in diabetic individuals by improving glycemic control. Tertiary prevention measures of MNT are directed at managing diabetes-related complications (cardiovascular disease, neuropathy) in diabetic individuals. Despite the popular notion, there is not any " Diabetic diet...
Post a Comment
Read more

PNEUMONIA- Its Etiology, Pathophysiology, Classification and Severity Assessment Method!

 PNEUMONIA Definition: "Pneumonia is an infection of pulmonary parenchyma". (Harrison)                                                    OR "Pneumonia is defined as an acute respiratory illness associated with recently developed radiological pulmonary shadowing which may be segmental, lobar or multilobar". (Davidson) Etiology: Microorganisms gain excess to the lower respiratory tract in several ways: Aspiration from the oropharynx (most common). Inhalation of contaminated droplets. Hematogenous spread. Contiguous extension. Pathophysiology of Pneumonia: Pneumonia results from proliferation of microbial pathogens at the alveolar level and the hosts response to these microorganisms.  Defensive Mechanisms against Pneumonia: The defensive mechanism against pneumonia involve: Branching architecture of tracheobronchial tree. Muco-ciliary clearance. Local...
Post a Comment
Read more

Anatomy and the Complications Associated with Liver Diseases!

  LIVER AND THE COMPLICATIONS ASSOCIATED WITH THE PROGRESSION OF DISEASE! Liver: The liver weighs up to 1.5kg in adults and is the 2nd largest organ in the body. Hepatocytes are the functioning unit of liver. Impairment of liver may lead to: Acute liver diseases Chronic liver diseases Liver cirrhosis Acute Liver Disease (ALD): ALD is a self-limiting episode of hepatocyte damage which in most cases spontaneously without clinical sequelae, but acute liver failure (ALF) may develop. This is a rare condition in which there is a rapid deterioration in liver function with associated encephalopathy and coagulopathy. ALF carries significant morbidity and mortality and may require emergency liver transplant. Chronic Liver Disease (CLD): CLD occurs when the longstanding cell damage causes permanent structural changes within the liver, with the loss of normal liver structure and functions. In many cases, this may lead to cirrhosis where fibrosis sears divide the liver cells into areas of rege...
Post a Comment
Read more